The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Ohio Sues Five Drug Companies Over Opioid Crisis

Ohio Sues Five Drug Companies Over Opioid Crisis

May 31, 2017 • By Chris Kenning

  • Tweet
  • Email
Print-Friendly Version / Save PDF

CHICAGO (Reuters)—Ohio Attorney General Mike DeWine said on Wednesday his office sued five major drug manufacturers, accusing them of misrepresenting the risks of prescription opioid painkillers and so helping fuel a sky-rocketing drug addiction epidemic.

You Might Also Like
  • U.S. State Attorneys General Probe Opioid Drug Companies
  • Missouri Sues Opioid Manufacturers, Joining Two other U.S. States
  • New Jersey Sues OxyContin Maker, Links Marketing to Opioid Crisis

A growing number of state and local governments are suing drugmakers and distributors, seeking to hold them accountable for the opioid crisis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The five companies Ohio sued were Purdue Pharma LP, Johnson and Johnson’s Janssen Pharmaceuticals Inc unit, a unit of Endo International Plc, Teva Pharmaceutical Industries Ltd’s Cephalon unit and Allergan Plc, DeWine said during a press conference in Columbus livestreamed online.

He argued the drug companies spent millions of dollars to promote the drugs for profit while denying or trivializing their potential addictive qualities.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“These companies continue to mislead the public,” DeWine said.

Janssen spokesman Jessica Castles Smith said in an emailed statement: “The allegations in this lawsuit are both legally and factually unfounded.”

She said Janssen has acted responsibly regarding its opioid pain medications, which are approved by the U.S. Food and Drug Administration and carry FDA-mandated warnings on their labels about the drugs’ known risks.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Purdue, which makes Oxycontin, said in an emailed statement: “We share the attorney general’s concerns about the opioid crisis and we are committed to working collaboratively to find solutions.”

The other companies did not immediately respond to a request for comment.

The suit, filed in Ross County, in Southern Ohio, where addiction has hit hard, also seeks damages for the money the state has spent on the fallout, DeWine said.

Opioid drugs, including prescription painkillers and heroin, killed more than 33,000 people in the United States in 2015, more than any year on record, according to the U.S. Centers for Disease Control and Prevention.

In Ohio, figures from 88 county coroners show that more than 4,100 people died from drug overdoses last year, according to figures compiled recently by the Columbus Dispatch.

Drug companies including Purdue Pharma LP and Johnson and Johnson have been fighting lawsuits by two California counties, the city of Chicago, four counties in New York and the state of Mississippi over their opioid marketing practices.

Several West Virginia counties have filed lawsuits in recent months against drug wholesalers McKesson Corp, Cardinal Health and AmerisourceBergen for failing to report suspicious orders of opioids in the state.

West Virginia’s attorney general earlier reached settlements with Cardinal Health and AmerisourceBergen for a combined $36 million to resolve similar claims.

Filed Under: Ethics, Professional Topics Tagged With: Allergan Plc., Endo International Plc, Janssen Pharmaceuticals Inc, Ohio lawsuit, opioid crisis, Purdue Pharma LP, Teva Pharmaceutical Industries Ltd’s Cephalon

You Might Also Like:
  • U.S. State Attorneys General Probe Opioid Drug Companies
  • Missouri Sues Opioid Manufacturers, Joining Two other U.S. States
  • New Jersey Sues OxyContin Maker, Links Marketing to Opioid Crisis
  • Washington State Sues OxyContin Maker Purdue Pharma

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.